Medpace Holdings, Inc.MEDPNASDAQ
Loading
EBITDA Over TimeExpanding
Percentile Rank100
3Y CAGR+22.4%
5Y CAGR+24.2%
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

3Y CAGR
+22.4%/yr
vs +21.1%/yr prior
5Y CAGR
+24.2%/yr
Consistent
Acceleration
+1.3pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
3x
Strong expansion
Streak
9 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$551.91M+15.9%
2024$476.12M+31.1%
2023$363.15M+20.6%
2022$301.04M+37.0%
2021$219.73M+17.8%
2020$186.57M+24.0%
2019$150.45M+7.6%
2018$139.85M+26.0%
2017$110.98M+11.6%
2016$99.45M-